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Background: A decline in the CD4 count is a common feature in 
HIV/AIDS, suggesting a compromise in immunity of patients. In 
response, highly active antiretroviral therapy (HAART) is prescribed 
to slow-down a diminution in the CD4 count and risk of AIDS-related 
malignancies. However, exercise may improve both the utility and 
population of innate immune cell components, and may be beneficial 
for patients with HIV infection. Comparing the effects of different 
exercises against HAART, on CD4 count, helps in understanding 
the role and evidence-based application of exercises to ameliorate 
immune deficiency.
Methods: Eighty-nine patients attending the HIV clinic at Enugu 
State University Teaching Hospital Parklane, Enugu, were studied 
in a single-blind, randomized controlled trial. The study measured 
the response of the patients’ CD4 count before and after 6 weeks of 
moderate-intensity aerobic (MIA) exercises, progressive resistance 
(PRE) exercises, and without exercise (control), involving subgroups 
of patients on HAART and HAART naive, respectively. All patients 
gave written informed consent after ethical approval was obtained 
and were educated on the use of the Borg rating of perceived exer-
tion scale. They exercised at a rating of perceived exertion of 10 to 
13 (interpreted as light to somewhat difficult) thrice weekly, at 30 
minutes per session. Data collected were analyzed by using repeated 
ANOVA and least significant difference for post hoc comparison at 
P < 0.05.
Results: There was a significant “within-subject” interaction effect 
for exercise and CD4 count (P < 0.0001) such that the CD4 count 
increased in all patients (HAART and HAART naive) on exercise 
(MIA and PRE) and decreased in patients who did not exercise, with 
equal effect size (d = 0.37), respectively. The highest positive and 
negative change factor for CD4 count was recorded in the control 
group that was on HAART (19.68%) and the MIA exercise group 
that were HAART-naive (–17.76%). However, whereas the PRE 
and MIA HAART and HAART-naive exercise subgroups recorded 
increases in CD4 count, the HAART and HAART-naive control sub-
groups recorded decreases in CD4 count.
S2 Abstract
Conclusions: These results suggest that an exercise (MIA and 
PRE) prescription for patients on HAART boosts their CD4 count. 
Importantly, CD4 count may be boosted more by MIA than by PRE 
exercises in patients on HAART and HAART-naive, respectively. The 
change factor suggests supports this conclusion and the effect size 
are of clinical significance.
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